Summary
- Current Price
- As of today, DNLI price is $20.23, down -0.74% in the most recent trading session on
- Current Price All-Time High
- DNLI price is currently -78.46% below its historical high of $93.94 set on
- Market Cap
- DNLI current market cap is $3B, up +67.39% over the past 365 days
- Revenue
- DNLI current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for DNLI is on
Profile
| Metric | Value |
|---|---|
| Full Name | Denali Therapeutics Inc. |
| Ticker | NASDAQ: DNLI |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | denalitherapeutics.com |
| Employees | 443 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $20.23 | |
| Price, 1D Change | -0.74% | |
| $3B | ||
| - | ||
| - | ||
| 1.50 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.97 | ||
| EPS, 1Y Change | -15.49% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$2.97 | ||
| EPS Estimate | -$2.35 | N/A |
| EPS Est. Change | +20.94% | N/A |
| $0.00 | ||
| Revenue Estimate | $50.26M | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $20.23 | |
| Price Target | $35.00 | - |
| Price Tgt. Change | +73.01% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.75 | -$2.57 | +6.50% | |
| -$3.01 | -$2.97 | +1.23% | |
| -$2.35 | N/A | +20.94% | |
| -$2.43 | N/A | +18.02% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $12.41M | $0.00 | -100.00% | |
| $2.86M | $0.00 | -100.00% | |
| $50.26M | N/A | - | |
| $126.88M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $20.23 | |
| $20.94 | ||
| $23.89 | ||
| $21.23 | ||
| $23.22 | ||
| -$0.89 | ||
| 1.50 | ||
| $0.83 | ||
| 26.09 | ||
| 20.31% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$2.97 | ||
| $0.00 | ||
| - | ||
| -$555.34M | ||
| - | ||
| -$512.54M | ||
| - | ||
| -$544.16M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.04 | ||
| 9.16 | ||
| 9.16 | ||
| - | ||
| - | ||
| 13.13 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 897.26 | ||
| 3.87 | ||
| -4.85 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $1.01B | ||
| $867.88M | ||
| $1.14B | ||
| $900.66M | ||
| $131.09M | ||
| $98.35M | ||
| $42.29M | ||
| $9.55M | ||
| $3.33M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $512.54M | ||
| $544.16M | ||
| $14.81M | ||
| $136.56M | ||
| $11.18M | ||
| $0.00 | ||
| $102.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$412.60M | ||
| $255.28M | ||
| $189.22M | ||
| $9.50M | ||
| -$422.10M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| B. Riley Securities | → | |
| UBS | → | |
| Morgan Stanley | → | |
| Deutsche Bank | → | |
| Morgan Stanley | → | |
| Morgan Stanley | → | |
| BTIG | → | |
| Wedbush | → | |
| Leerink Partners | → | |
| Baird | → |
Analyst sentiment
Institutional ownership
No data
Screeners with DNLI
FAQ
- What is the ticker symbol for Denali Therapeutics Inc.?
- The ticker symbol for Denali Therapeutics Inc. is NASDAQ:DNLI
- Does Denali Therapeutics Inc. pay dividends?
- No, Denali Therapeutics Inc. does not pay dividends
- What sector is Denali Therapeutics Inc. in?
- Denali Therapeutics Inc. is in the Healthcare sector
- What industry is Denali Therapeutics Inc. in?
- Denali Therapeutics Inc. is in the Biotechnology industry
- What country is Denali Therapeutics Inc. based in?
- Denali Therapeutics Inc. is headquartered in United States
- When did Denali Therapeutics Inc. go public?
- Denali Therapeutics Inc. initial public offering (IPO) was on December 8, 2017
- Is Denali Therapeutics Inc. in the S&P 500?
- No, Denali Therapeutics Inc. is not included in the S&P 500 index
- Is Denali Therapeutics Inc. in the NASDAQ 100?
- No, Denali Therapeutics Inc. is not included in the NASDAQ 100 index
- Is Denali Therapeutics Inc. in the Dow Jones?
- No, Denali Therapeutics Inc. is not included in the Dow Jones index
- When was Denali Therapeutics Inc. last earnings report?
- Denali Therapeutics Inc.'s most recent earnings report was on August 6, 2026
- When does Denali Therapeutics Inc. report earnings?
- The next expected earnings date for Denali Therapeutics Inc. is November 5, 2026
Data Sources & References
- DNLI Official Website www.denalitherapeutics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1714899/000171489926000021/0001714899-26-000021-index.htm
- DNLI Profile on Yahoo Finance finance.yahoo.com/quote/DNLI
- DNLI Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dnli